Narjes Nasiri‐Ansari

35 papers receiving 995 citations

Hit Papers

Empagliflozin Attenuates Non-Alcoholic Fatty Liver Diseas...20212026202220242021202250100150200

Peers

Narjes Nasiri‐Ansari
Comparison fields: 5 of 89
  • Epidemiology 456
  • Endocrinology, Diabetes and Metabolism 415
  • Molecular Biology 303
  • Surgery 230
  • Physiology 129
Replace Teruo Jojima with:
Teruo Jojima Japan
Shiying Liu China
Nobuhiko Wada Japan
Sara A. Beddow United States
Jinhang Zhang China
Blas A. Guigni United States
Satish RamachandraRao United States
Taro Wasada Japan
George G. Schweitzer United States
Laia Vilà Spain
Narjes Nasiri‐Ansari relative to Teruo Jojima Japan Teruo Jojima's profile →
Citations per field
00.5×1.5×2.0×
Teruo Jojima · 1×
Citations per year

Countries citing papers authored by Narjes Nasiri‐Ansari

Since Specialization
Citations

This map shows the geographic impact of Narjes Nasiri‐Ansari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narjes Nasiri‐Ansari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narjes Nasiri‐Ansari more than expected).

Fields of papers citing papers by Narjes Nasiri‐Ansari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narjes Nasiri‐Ansari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narjes Nasiri‐Ansari. The network helps show where Narjes Nasiri‐Ansari may publish in the future.

Co-authorship network of co-authors of Narjes Nasiri‐Ansari

This figure shows the co-authorship network connecting the top 25 collaborators of Narjes Nasiri‐Ansari. A scholar is included among the top collaborators of Narjes Nasiri‐Ansari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narjes Nasiri‐Ansari. Narjes Nasiri‐Ansari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 18
2 3
3 2
4 5
5 64
6 8
7 8
8 2
9
Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosisbreakdown →
234
10 5
11 59
12 0
13 23
14 3
15 43
16 125
17 16
18 8
19 4
20 35

About Narjes Nasiri‐Ansari

Narjes Nasiri‐Ansari is a scholar working on Endocrine and Autonomic Systems, Endocrinology, Diabetes and Metabolism and Aging, having authored 36 papers that have together received 1.0k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (7 papers), Circadian rhythm and melatonin (6 papers) and Diet, Metabolism, and Disease (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (415 citations), Epidemiology (456 citations) and Hepatology (85 citations). Narjes Nasiri‐Ansari has collaborated with scholars based in Greece, United Kingdom and United States. Frequent co-authors include Eva Kassi, Harpal Randeva, Gregory Kaltsas, Ioannis Kyrou, Athanasios G. Papavassiliou, Christina‐Maria Flessa, Θεόδωρος Ανδρουτσάκος, Antonios Chatzigeorgiou, Georgios Kyriakopoulos and Georgios Agrogiannis. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences and Cellular and Molecular Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026